Grufity logo
Grufity logo

Latest Blue Owl Capital Holdings LP Stock Portfolio

$372Million | No. of Holdings #68

Blue Owl Capital Holdings LP Performance

2026 Q1+0.45%
YTD+0.45%
2025-3.75%

About Blue Owl Capital Holdings LP and 13F Hedge Fund Stock Holdings

On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Blue Owl Capital Holdings LP reported an equity portfolio of $372.2 Millions as of 31 Mar, 2026. <br><br> The top stock holdings of Blue Owl Capital Holdings LP are , LRMR, . The fund has invested 15.2% of it's portfolio in AKTIS ONCOLOGY INC and 8.6% of portfolio in LARIMAR THERAPEUTICS INC . <br><br> The fund managers got completely rid off REPARE THERAPEUTICS INC (RPTX), PROCORE TECHNOLOGIES INC (PCOR) and ROIVANT SCIENCES LTD (ROIV) stocks. They significantly reduced their stock positions in DELL TECHNOLOGIES INC (DELL), SAGIMET BIOSCIENCES INC and ORIC PHARMACEUTICALS INC (ORIC). Blue Owl Capital Holdings LP opened new stock positions in AKTIS ONCOLOGY INC, CORVUS PHARMACEUTICALS INC (CRVS) and RHYTHM PHARMACEUTICALS INC (RYTM). The fund showed a lot of confidence in some stocks as they added substantially to ENGENE HOLDINGS INC, AQUESTIVE THERAPEUTICS INC (AQST) and EYEPOINT INC (EYPT).
Blue Owl Capital Holdings LP Equity Portfolio Value
Last Reported on: 14 May, 2026
$372Million
  as of May 14, 2026

Blue Owl Capital Holdings LP Annual Return Estimates Vs S&P 500

Our best estimate is that Blue Owl Capital Holdings LP made a return of 0.45% in the last quarter. In trailing 12 months, it's portfolio return was 27.63%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
aktis oncology inc56,556,500
corvus pharmaceuticals inc7,973,350
rhythm pharmaceuticals inc5,344,740
ovid therapeutics inc4,228,360
starwood ppty tr inc 2,730,140
evommune inc2,299,000
ww intl inc1,314,010
piper sandler companies 185,863
New stocks bought by Blue Owl Capital Holdings LP

Additions

Ticker% Inc.
engene holdings inc 1,316
lenz therapeutics inc 237
maplight therapeutics inc207
aquestive therapeutics inc156
eyepoint inc 132
cid holdco inc48.17
ultragenyx pharmaceutical in 42.33
engene holdings inc31.4
Additions to existing portfolio by Blue Owl Capital Holdings LP

Reductions

Ticker% Reduced
dell technologies inc-74.19
sagimet biosciences inc-73.16
oric pharmaceuticals inc -70.87
niocorp devs ltd -63.47
civeo corp cda -51.29
stardust pwr inc -47.37
immix biopharma inc-44.48
kalvista pharmaceuticals inc -40.28
Blue Owl Capital Holdings LP reduced stake in above stock

Sold off

Ticker$ Sold
repare therapeutics inc-8,953,510
alpha tau medical ltd-396,480
payoneer global inc-3,978,330
immuneering corp-4,375,700
livewire group inc -30,000
compass pathways plc-3,242,410
roivant sciences ltd-5,712,500
zeo energy corp-10,000
Blue Owl Capital Holdings LP got rid off the above stocks

Sector Distribution

Blue Owl Capital Holdings LP has about 48.7% of it's holdings in Others sector.

  • Others
  • Healthcare
  • Consumer Cyclical
  • Technology
  • Industrials
Sector%
Others48.7
Healthcare42.5
Consumer Cyclical3.9
Technology2.4
Industrials1.3

Market Cap. Distribution

Blue Owl Capital Holdings LP has about 1.1% of it's portfolio invested in the large-cap and mega-cap stocks.

  • UNALLOCATED
  • SMALL-CAP
  • MICRO-CAP
  • MID-CAP
  • LARGE-CAP
Category%
UNALLOCATED48.7
SMALL-CAP27
MICRO-CAP20.7
MID-CAP2.3
LARGE-CAP1.1

Stocks belong to which Index?

About 36.2% of the stocks held by Blue Owl Capital Holdings LP either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others63.7
RUSSELL 200036.2
Top 5 Winners (%)%
brand engagement network inc
423.0 %
syntec optics hldgs inc
350.0 %
xbp global holdings inc
100.1 %
ELDN
eledon pharmaceuticals inc
90.2 %
baird med invt hldgs ltd
80.0 %
Top 5 Winners ($)$
CGEM
cullinan therapeutics inc
8.2 M
CNTX
context therapeutics inc
7.2 M
LRMR
larimar therapeutics inc
4.8 M
IMMX
immix biopharma inc
3.0 M
ELDN
eledon pharmaceuticals inc
2.6 M
Top 5 Losers (%)%
PGY
pagaya technologies ltd
-87.5 %
bitcoin depot inc
-81.8 %
DAVE
dave inc
-72.5 %
cid holdco inc
-71.5 %
cid holdco inc
-62.2 %
Top 5 Losers ($)$
engene holdings inc
-8.6 M
HLLY
holley inc
-4.4 M
EYPT
eyepoint inc
-3.5 M
blue owl capital corporation
-3.5 M
CNDT
conduent inc
-3.2 M

Blue Owl Capital Holdings LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Blue Owl Capital Holdings LP

Blue Owl Capital Holdings LP has 68 stocks in it's portfolio. About 69.3% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. CGEM was the most profitable stock for Blue Owl Capital Holdings LP last quarter.

$363.93MTotal Value
93.00Positions
14 May, 2026Last Reported
Current holdings of Current Stock Holdings of Blue Owl Capital Holdings LP, last reported on 14 May, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ADCT
Adc Therapeutics Sa

Adc Therapeutics Sa

ADCT
Blue Owl Capital Holdings LP's holding in Adc Therapeutics Sa over time
0.7%733,568
$2.59M
0.7%
unchanged 0 percentunchanged
CMPS
Compass Pathways Plc

Compass Pathways Plc

CMPS
Blue Owl Capital Holdings LP's holding in Compass Pathways Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off
DRTS
Alpha Tau Medical Ltd

Alpha Tau Medical Ltd

DRTS
Blue Owl Capital Holdings LP's holding in Alpha Tau Medical Ltd over time
0%0.00
$0.00
0%
decreased 100 percentsold off
EMLD
Fold Hldgs Inc

Fold Hldgs Inc

EMLD
Blue Owl Capital Holdings LP's holding in Fold Hldgs Inc over time
0.3%856,632
$1.13M
0.3%
unchanged 0 percentunchanged